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Abstract
Leukocytes comprise less than 1% of all blood cells. Enrichment of their number, starting from a
sample of whole blood, is the required first step of many clinical and basic research assays. We
created a microfluidic device that takes advantage of the intrinsic features of blood flow in the
microcirculation, such as plasma skimming and leukocyte margination, to separate leukocytes
directly from whole blood. It consists of a simple network of rectangular microchannels designed
to enhance lateral migration of leukocytes and their subsequent extraction from the erythrocyte-
depleted region near the sidewalls. A single pass through the device produces a 34-fold
enrichment of the leukocyte-to-erythrocyte ratio. It operates on microliter samples of whole blood,
provides positive, continuous flow selection of leukocytes, and requires neither preliminary
labeling of cells nor input of energy (except for a small pressure gradient to support the flow of
blood). This effortless, efficient, and inexpensive technology can be used as a lab-on-a-chip
component for initial whole blood sample preparation. Its integration into microanalytical devices
that require leukocyte enrichment will enable accelerated transition of these devices into the field
for point-of-care clinical testing.
The rapidly expanding field of lab-on-a-chip microanalytical devices promises inexpensive,
portable, miniaturized tools that could potentially revolutionize clinical and basic research
analyses by dramatically reducing sample size and handling.1-3 An important application of
this technology is the analysis of leukocytes (white blood cells) or their contents, for which
these cells must first be isolated from the whole blood sample.4-7
Blood is a 45% suspension of cells (erythrocytes, platelets, leukocytes) in plasma.
Erythrocytes (red blood cells) constitute the vast majority of all blood cells and are normally
∼1000 times more abundant than leukocytes. Traditionally, several milliliters of whole
blood are drawn and then centrifuged in order to separate blood cells of different density.
Plasma, platelets, and white and red cells can be separated by this procedure, but it is a
labor-, energy-, and time-intensive process that relies on special equipment and requires
trained personnel.8,9 Many current microanalytical devices have no integrated sample
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preparation capabilities and continue to rely on this conventional off-the-chip technique.
Currently available methods that can be used for on-the-chip enrichment of leukocytes from
whole blood are often complicated, lack versatility, offer low efficiency, or require
preliminary modification of cells.3,6-8,10 Thus, development of simple and efficient
methods to isolate leukocytes directly from whole blood remains an important task.
Because of its particulate nature, blood exhibits unique flow characteristics on the scale of
the microcirculation.11 Erythrocytes, which are smaller and more deformable than
leukocytes, tend to flow at the center of blood vessels, leaving a plasma-rich zone adjacent
to the vessel wall;12 they also flow faster than leukocytes.13 This encourages mechanical
interactions (collisions) between leukocytes and erythrocytes that influence the leukocyte
distribution across the vessel lumen13,14 and among vessels of the microcirculation in vivo.
15,16 In vessels larger than ∼30 μm in diameter, collisions with passing erythrocytes force
leukocytes to migrate toward the vessel wall in a process known as margination13,17,18 and
help to initiate leukocyte rolling in post-capillary venules.19-22 The tendency of erythrocytes
to concentrate at the center of the blood stream also leads to plasma skimmings an uneven
distribution of erythrocytes and plasma among the two daughter vessels of any
nonsymmetrical bifurcation:23 the vessel that receives less flow receives a
disproportionately smaller fraction of erythrocytes and, therefore, has a lower hematocrit.
Previously, we used silicon micromachining and poly(dimethylsiloxane) (PDMS) replica
molding techniques24-27 to fabricate microchannel networks with dimensions and topology
similar to those of the actual microcirculation.24 Using whole human blood, we were able to
reproduce and document a number of scale-specific microcirculatory phenomena in such
networks.
Here, we describe the operation principle and demonstrate the efficiency of a simple
microfluidic device that takes advantage of the natural flow properties of blood (leukocyte
margination and plasma skimming) to separate leukocytes from whole blood. It consists of a
network of rectangular microchannels of specific geometry and connectivity and requires
only a small pressure gradient to produce a 34-fold enrichment of the leukocyte-to-
erythrocyte ratio in a single pass. The unique biomimetic design of this microchannel device
allows, in fact, autoseparation of leukocytes from the rest of the blood. This novel leukocyte
enrichment technique could be used to design custom lab-on-a-chip components for
integrated sample preparation in microanalytical devices that require leukocytes, their DNA,
or RNA.3,6,7
EXPERIMENTAL SECTION
Microfabrication
Fabrication of microchannel networks and the experimental setup were previously described
in detail.24,25 Briefly, a silicon wafer containing a negative image of the microchannel
device was created at the CNF (Cornell Nanofabrication Facility, Cornell University, Ithaca,
NY) using electron beam lithography (EBMF-10.5/CS, Cambridge Instruments) and reactive
ion etching (Bosch process, Unaxis SLR 770 ICP Deep Silicon Etcher, Unaxis USA Inc., St.
Petersburg, FL) techniques. This master wafer was then used as a negative mold to cast
replicas of the device in PDMS (RTV 615 A/B; G. E. Silicones, Waterford, NY). Each of
these cast replicas was then trimmed to size and affixed onto a predrilled, PDMS-coated
glass slide (Micro Slides; VWR Scientific, West Chester, PA) to form the microchannel
device. Before assembly, all contact surfaces were exposed to air plasma (Plasma Cleaner/
Sterilizer, Harrick Scientific Corp., Ossining, NY). This treatment generates silanol (Si–OH)
groups on exposed PDMS surfaces, which provides permanent binding between the cast
microchannels and the PDMS-coated glass slide; it also makes the microchannel wall
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surfaces hydrophilic.27 Assembled microdevices were flushed with 1% (w/v) aqueous
solution of mPEG-silane (Shearwater Polymers, Inc., Huntsville, AL) to prevent cell
adhesion and then washed with GASP buffer (1% BSA, 9 mM Na2HPO4, 1.3 mM
NaH2PO4, 140 mM NaCl, 5.5 mM glucose, pH 7.4, osmolarity 290 mmol/kg).
Setup
The microchannel device assembly was mounted in a custom holder on a calibrated
motorized microscope stage (BX-51, Olympus America Inc, Melville, NY). A water column
was used to provide the operational pressure gradient of 5−40 cmH2O across the
microchannel flow system. Sequences of images were acquired with a CMOS digital camera
(Silicon Video 2112, Epix Inc., Buffalo Grove, IL) using a wide band-pass blue-violet filter
(407 ± 52 nm, Edmund Industrial Optics, Barrington, NJ) to improve contrast. Images were
recorded and then analyzed off-line using custom software (designed using Matlab 6.5, The
Math Works Inc, Natick, MA) to determine white cell distributions and the leukocyte-to-
erythrocyte ratios in the extraction channel. All microchannels of the device had the same
depth of 10.3 μm. Blood samples were introduced into a feeding reservoir incised in the
PDMS replica to provide access to the channels. Blood exited the device through a 2-mm
hole drilled through the glass slide and then drained into a waste collection reservoir. In the
configuration described here, 15−70 μL of blood (depending on the size of the feeding
reservoir) is required for operation.
Samples
Whole human blood was collected by venipuncture from healthy consenting volunteers into
Vacutaner tubes containing EDTA (10 mL, 17.55 mg of (K3)EDTA, BD, Franklin Lakes,
NJ) similar to the standard clinical procedure. Initial red and white cell concentrations in
whole blood were determined in duplicate using a Sysmex K-1000 automated cell counter
(Sysmex Corp. of America, Long Grove, IL). Blood samples were used within 4 h of
collection.
RESULTS AND DISCUSSION
The microseparation device measures ∼0.7 × 7 mm and consists of a simple network of
microchannels schematically shown in Figure 1. Flow of blood through the device is driven
by a small pressure gradient (∼40 cmH2O). The device operates as follows:
Whole blood enters the device through a 70-μm-wide supply channel. Initially, leukocytes
are distributed uniformly across the channel (Figure 1, 1). As smaller, more flexible
erythrocytes seek the faster flow region in the center of the channel lumen,28 they collide
with leukocytes forcing them to migrate toward the sidewalls.18 Therefore, before the first
bifurcation is reached, the leukocyte distribution across the channel changes considerably,
with most of the leukocytes traveling near the channel sidewalls (Figure 1, 3).
This phenomenon of leukocyte margination in the supply channel appears more dramatic
than that observed in real blood vessels. The depth of all channels comprising the device
(10.3 μm) approximates the average leukocyte diameter (10−12 μm), such that out-of-the-
plane motion of leukocytes is effectively restricted. Due to this pseudo-2D geometry,
practically all erythrocyte–leukocyte collisions result in lateral migration of the leukocytes
toward the nearest sidewall. In contrast, margination in real blood vessels is less efficient
because migration of leukocytes is not constrained to any preferential direction. Therefore,
when leukocytes marginate in vivo, they approach the vessel wall via a random walk (that
reflects collisions with erythrocytes from multiple angles) and arrive at points scattered
around the vessel perimeter.18
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The concentration of leukocytes in the blood immediately after entering the supply channel
(2100/μL, Figure 1, 1) is less than half that in the original whole blood sample (4300/μL).
This is because erythrocytes and plasma flow more easily than leukocytes from the sample
reservoir, effectively lowering leukocyte concentration. This phenomenon likely reflects
specific design features of the current sample introduction system.
As leukocytes marginate to the sidewalls, they begin to flow slower than the rest of the
blood, because of the shape of the velocity profile in the channel.29-31 This results in gradual
accumulation of leukocytes traveling adjacent to the sidewalls and thus leads to the increase
of overall leukocyte concentration along the supply channel (Figure 1, 1−3). A flux balance
shows that the leukocyte concentration (C) ratio between any two points along the channel is
determined by the average leukocyte velocities (vi): C2/C1 = v1/v2. In the case shown in
Figure 1, the velocity ratio is ∼2; i.e., the concentration of leukocytes increases ∼2-fold
along the supply channel, reaching 4500/μL (Figure 1, 3). Note that this value is almost
equal to that in the original sample. Thus, the gradual accumulation of leukocytes along the
supply channel compensates the 2-fold reduction of leukocyte concentration caused by
dynamic dilution at the entry into the channel.
After passing through the first bifurcation, leukocytes continue to travel near the outside
wall of each daughter channel. These two channels have equivalent asymmetric leukocyte
distribution profiles, and either can be used for further processing. The asymmetry in
leukocyte distribution in segment 4 causes the majority of the leukocytes to enter segment 6
of the second bifurcation, with very few entering segment 5 (data not shown). This further
increases the leukocyte concentration in segment 6 by ∼2-fold. The asymmetry persists here,
with most leukocytes remaining near the right-hand sidewall.
The main part of the leukocyte enrichment device consists of a 135° bend 6 with a small
extraction channel 8. The bend alters the velocity profile32 causing erythrocytes to move
quickly around the inside, bypassing leukocytes that travel more slowly in the plasma-rich
region near the sidewall. As the erythrocytes pass the slower leukocytes, they trap them near
the wall and propel them into the extraction channel (Figure 1, asterisk; movie S-1,
Supporting Information). Approximately 67% of all leukocytes from the segment 6 enter the
extraction channel 8; the rest continue along the right-hand sidewall of the adjacent, larger
channel 7 with a characteristic asymmetric distribution (Figure 1). Compared to the initial
whole blood sample, the leukocyte concentration in the extraction channel 8 is increased
∼10-fold, achieving 42 300/μL.
Both leukocyte margination and plasma skimming are principally important for the
enrichment function of the device: accumulation of leukocytes near the sidewall in the
plasma-rich region causes ∼2/3 of them to enter the extraction channel; at the same time,
plasma skimming reduces the erythrocyte concentration in the extraction channel to less
than 1/3 of its initial value. Note that “plasma skimming” in this context differs somewhat
from its conventional definition due to the high concentration of leukocytes in the plasma
rich region. The combined effect of these phenomena translates into an increase in the
leukocyte-to-erythrocyte ratio from 1:1100 in the original blood sample to 1:32 in the
extraction channel (Figure 1, 8)—a 34-fold enrichment.
Any practical microanalytical device for point-of-care use must incorporate a robust and
convenient way to prepare a sample directly on the chip to minimize the required raw
sample size and potential user-induced errors.1-3 Most current prototypes, however,
concentrate more on the analysis and quantification steps, rather than integrated sample
preparation procedures, either because sample preparation is often the most difficult33 or
least exciting7 part of the assay.10 Thus, even though such devices generally require only
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submicroliter sample volumes for analysis, off-the-chip sample preparation via conventional
centrifugation may require several milliliters of blood.8,9
Currently available approaches to on-the-chip sample preparation are based on
filtration4,8,33 or dielectrophoresis (DEP)34 or require preliminary cell modification steps
such as fluorescent labeling35,36 or tagging with magnetic beads.37,38 The current state of
the art of these and other sample preparation methods is the focus of recent reviews.3,6,7,10
The new leukocyte enrichment method described here has many important advantages over
these technologies. It is simple, has no active (moving or otherwise) elements, requires only
a small hydrostatic pressure gradient to function, and can be easily manufactured using
conventional microfabrication. Further, it operates on (anticoagulated) whole blood, actually
benefiting from physiological levels of hematocrit—the same factor that confounds other
sample preparation techniques. It provides positive selection of leukocytes, which are not
trapped in a specific area of the chip (in contrast to both filtration33 and DEP34) but
continue to flow and can be easily transported elsewhere on the chip for further purification
or directly to analytical unit(s) for examination. Importantly, leukocyte handling (and thus
potential leukocyte activation) is minimized and no cell preprocessing is required, as
opposed to fluorescence or magnetically activated cell separation procedures.35-38
The separation is efficient, producing a greater than 30-fold increase in the leukocyte-to-
erythrocyte ratio in a single pass. This is higher than that of a single-spin centrifugation
“buffy coat” preparation of whole human blood (∼10−20-fold enrichment) and is sufficient
for many applications such as PCR, which requires at least a 10-fold enrichment.8
Future work is needed to improve purity and provide better characterization of this new
leukocyte enrichment technique. For example, modification of the input reservoir may
eliminate the initial dynamic reduction of leukocyte concentration caused by the impeded
traffic of leukocytes during their entry into the supply channel (Figure 1, 1). In addition,
separation units can be arranged in series to further purify the extraction channel effluent
(Figure 1, 8). However, the low hematocrit (∼1/3 of initial sample) and high leukocyte
concentration (∼10 times higher than in initial sample) characteristic of the effluent may
diminish the efficiency of secondary separation. Decreased frequency of erythrocyte–
leukocyte collisions and increased number of leukocyte–leukocyte interactions could hinder
leucocyte margination and reduce separation efficiency. Another possible approach aimed at
higher separation efficiency would involve coating the supply channel walls with adhesion
molecules, such as P-selectin, which mediate leukocyte rolling in vivo. This slow “adhesive”
rolling of leukocytes would facilitate their accumulation along the supply channel and may
improve overall enrichment.
CONCLUSIONS
An obvious advantage of applying a biomimetic approach to the design of microfluidic lab-
on-a-chip components is that the technical solutions that we borrow from nature have been
already rigorously tested, optimized, and approved by evolution. Examples of successful
application of this approach include check valves39 and adhesion-based cell separation.40 In
this paper, we described a new, simple method for obtaining highly enriched leukocytes
from a small sample of whole blood, the design of which has been inspired by natural
microcirculatory phenomena. This technique could be used as an initial sample preparation
step for the miniature analytical assays that require leukocytes or their genetic material. By
providing convenient and efficient sample preparation in situ, this technology should
facilitate implementation and commercialization of future lab-on-a-chip devices.
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Figure 1.
Microseparation device. The geometry of the device is illustrated in the center; snapshots
and plots of leukocyte (WBC) distributions are shown at the sides of the figure. Blood enters
the supply channel from the sample reservoir (not shown). Flow is from top to bottom in all
segments. All channels in the device are drained into a low-pressure reservoir (not shown).
The circled numbers correspond to points referenced in the text. Length of the supply
channel (points 1−3) is ∼5.5 mm; distance between the first and the third bifurcation is 0.48
mm. Flow rates in segments 7 and 8 were approximately 120 and 16 pL/s, respectively.
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